The High Cost Of Sex: Insurers Often Don鈥檛 Pay For Drugs To Treat Problems
Medicare and many private insurers view prescribing drugs to improve sexual function as a lifestyle issue that鈥檚 not medically necessary to pay for.
Drugs
821 - 840 of 1,288 Results
-
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 ‘Medicare-For-All’ For Dummies
The 鈥淢edicare鈥揻or-all鈥 debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner for a beginner鈥檚 guide to the next big health policy debate. For 鈥渆xtra credit,鈥 the panelists provide their favorite health policy stories of the week, and as a special Valentine鈥檚 Day bonus, their favorite #HealthPolicyValentines.
-
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money 鈥 one he hopes other states can join.
-
Americans Cross Border Into Mexico To Buy Insulin At A Fraction Of U.S. Cost
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
-
False Lead: Senator鈥檚 Offer To Help Patient Import Cheap Insulin Goes Nowhere
Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesn鈥檛 appear to exist.
By Jay Hancock -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
What 鈥楧ope Sick鈥 Really Feels Like
Just as each person鈥檚 journey into addiction is unique, different approaches work for people trying to find their way out. For me, detoxing was nightmarish. And a long-held dream come true.
By Brian Rinker -
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 A 鈥楬ealthy鈥 State Of The Union
Health was a featured player in President Donald Trump鈥檚 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and, for 鈥渆xtra credit,鈥 provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current 鈥淏ill of the Month鈥 feature.
-
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren鈥檛 For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven鈥檛 reached the market.
By Sydney Lupkin and Jay Hancock -
Trump Highlights Health Agenda With Vow To Lower 鈥楿nfair鈥 Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
By Julie Rovner -
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a 鈥渟hadowy system of kickbacks鈥 in the drug industry pipeline.
By Jay Hancock -
Lawsuit Details How The Sackler Family Allegedly Built An OxyContin Fortune
WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN鈥檚 Julie Rovner to discuss these issues and take questions from a live studio audience.
-
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients鈥 families weigh in with tragic stories.
By Emmarie Huetteman and Rachel Bluth -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Drug-Pricing Policies Find New Momentum As 鈥楢 2020 Thing鈥
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It鈥檚 not yet clear, though, which if any could go the distance.
-
Listen: ‘Death Certificate Project’ Aims At Opioid Crisis, But Doctors Cry Foul
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
-
Doctors Call California鈥檚 Probe Of Opioid Deaths A 鈥榃itch Hunt鈥
In a unique crackdown on what it sees as 鈥渆xcessive prescribing,鈥 the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses 鈥 whether or not the doctors prescribed the fatal medications.
By Cheryl Clark -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.